Usefulness of the aldosterone synthase gene polymorphism C-344-T to predict cardiac remodeling in African-Americans versus non-African-Americans with chronic systolic heart failure.
暂无分享,去创建一个
J. Loscalzo | F. Sam | E. Kotlyar | D. Allensworth-Davies | A. Biolo | Toni-Ann S. Duhaney | Tania Chao
[1] J. Loscalzo,et al. Predictors of improved left ventricular systolic function in an urban cardiomyopathy program. , 2006, The American journal of cardiology.
[2] Anne L. Taylor,et al. Aldosterone synthase promoter polymorphism predicts outcome in African Americans with heart failure: results from the A-HeFT Trial. , 2006, Journal of the American College of Cardiology.
[3] L. Cupples,et al. The relationship between aldosterone, oxidative stress, and inflammation in chronic, stable human heart failure. , 2006, Journal of cardiac failure.
[4] J. Ornato,et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult—Summary Article , 2005 .
[5] F. Cappuccio,et al. Aldosterone synthase gene (CYP11B2) C-344T polymorphism, plasma aldosterone, renin activity and blood pressure in a multi-ethnic population , 2004, Journal of hypertension.
[6] Zhonglin Xie,et al. Mice lacking osteopontin exhibit increased left ventricular dilation and reduced fibrosis after aldosterone infusion. , 2004, American journal of hypertension.
[7] B. Morris,et al. Haplotype analysis of aldosterone synthase gene (CYP11B2) polymorphisms shows association with essential hypertension , 2003, Journal of hypertension.
[8] B. Pitt,et al. Eplerenone, a Selective Aldosterone Blocker, in Patients with Left Ventricular Dysfunction after Myocardial Infarction , 2003 .
[9] A. Onipinla,et al. Contrasting associations between aldosterone synthase gene polymorphisms and essential hypertension in blacks and in whites , 2003, Journal of hypertension.
[10] C. Iwai,et al. Association between aldosterone synthase (CYP11B2) gene polymorphism and left ventricular volume in patients with dilated cardiomyopathy , 2002, Heart.
[11] K. Weber,et al. Aldosterone-induced inflammation in the rat heart : role of oxidative stress. , 2002, The American journal of pathology.
[12] S. Kardia,et al. Synergistic Polymorphisms of β1- and α2C-Adrenergic Receptors and the Risk of Congestive Heart Failure , 2002 .
[13] K. Sliwa,et al. An aldosterone synthase gene variant is associated with improvement in left ventricular ejection fraction in dilated cardiomyopathy. , 2002, Cardiovascular research.
[14] T. Ishimitsu,et al. Positive association of CYP11B2 gene polymorphism with genetic predisposition to essential hypertension , 2002, Journal of Human Hypertension.
[15] E. Antman,et al. ACC/AHA PRACTICE GUIDELINES ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary , 2002 .
[16] K. Weber. Aldosterone in congestive heart failure. , 2001, The New England journal of medicine.
[17] C. Yancy. Heart failure in blacks: Etiologic and epidemiologic differences , 2001, Current cardiology reports.
[18] C. Yancy. Heart failure in African Americans: A cardiovascular enigma , 2000 .
[19] B. Pitt,et al. The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure , 2000 .
[20] L. Tiret,et al. Lack of association between polymorphisms of eight candidate genes and idiopathic dilated cardiomyopathy: the CARDIGENE study. , 2000, Journal of the American College of Cardiology.
[21] B. Pitt,et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. , 1999, The New England journal of medicine.
[22] F. Soubrier,et al. Genotype-phenotype relationships for the renin-angiotensin-aldosterone system in a normal population. , 1999, Hypertension.
[23] B. Gersh,et al. Racial differences in the outcome of left ventricular dysfunction. , 1999, The New England journal of medicine.
[24] J. Connell,et al. Aldosterone excretion rate and blood pressure in essential hypertension are related to polymorphic differences in the aldosterone synthase gene CYP11B2. , 1999, Hypertension.
[25] F. Cambien,et al. Genetic determination of plasma aldosterone levels in essential hypertension. , 1998, American journal of hypertension.
[26] P. White,et al. Associations between human aldosterone synthase (CYP11B2) gene polymorphisms and left ventricular size, mass, and function. , 1998, Circulation.
[27] A. Struthers. Aldosterone escape during angiotensin-converting enzyme inhibitor therapy in chronic heart failure. , 1996, Journal of cardiac failure.
[28] P. White,et al. Haplotype analysis of CYP11B2. , 1995, Endocrine research.
[29] K. Swedberg,et al. Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group. , 1990, Circulation.
[30] N. Reichek,et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. , 1989, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[31] N. Reichek,et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. , 1986, The American journal of cardiology.
[32] A. DeMaria,et al. Recommendations Regarding Quantitation in M-Mode Echocardiography: Results of a Survey of Echocardiographic Measurements , 1978, Circulation.